Diagnostic Considerations
Q fever is difficult to diagnose, primarily because physicians tend not to think of it in the differential diagnosis. Failure to consider the diagnosis and failure to maintain an epidemiologic approach with any cluster of clinical presentations, particularly atypical pneumonia or hepatitis, eliminates any possibility of making the diagnosis.
The Centers for Disease Control and Prevention (CDC) recommends that physicians evaluate travelers, particularly military personnel and civilian contractors, for Q fever if they present with febrile illness, pneumonia, or hepatitis.[16] Confirmed and suspected cases should be reported to local health departments.
Consider the possibility of tick-borne illnesses in all patients with febrile illnesses. Also, exposures to animals, animal by-products, and parturient animals are risk factors. In patients with culture-negative endocarditis, consider infection with C burnetii.
In this age of concern for terrorism with biologic agents, Q fever is on the list of possible agents. The initial diagnosis might be delayed by the fact that it is so uncommon in most locations.[7]
Other conditions that are considered in the differential diagnosis include the following:
- Acute interstitial pneumonitis
- Arbovirus encephalitis
- Atypical pneumonia caused by viruses, Chlamydia species, or Mycoplasma
- Bacterial and infective endocarditis, bacterial pericarditis
- Chlamydial infections
- Connective-tissue diseases
- Hepatitis: Drug-induced, granulomatous, viral
- Ebstein-Barr virus
- Mediterranean fever
- Meningoencephalitis, aseptic meningitis
- Osteomyelitis or osteoarticular Infection
- Southern tick-associated rash illness (STARI)
- Spontaneous abortion, placentitis
- Tick-borne diseases (Colorado tick-borne diseases, ehrlichiosis, Lyme disease, relapsing fever, Rocky Mountain spotted fever, tularemia)
- TORCH syndrome (toxoplasmosis, rubella, cytomegalovirus, and herpes simplex infections)
- Vascular graft infections
- Visceral leishmaniasis
Differential Diagnoses
- Abortion
- Chronic Fatigue Syndrome
- Cytomegalovirus
- Fever of Unknown Origin
- Hodgkin Disease
- Influenza
- Legionella Infection
- Non-Hodgkin Lymphoma
- Rickettsial Infection
- Sarcoidosis
Centers for Disease Control and Prevention. Emergency preparedness and response: bioterrorism agents/diseases. Available at http://www.bt.cdc.gov/agent/agentlist-category.asp. Accessed October 6, 2011.
Marrie TJ, Raoult D. Coxiella burnetii (Q fever). In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 6th ed. Philadelphia, Pa: Churchill Livingstone; 2005:2296-303.
Samuel JE, Hendrix LR. Laboratory maintenance of Coxiella burnetii. Curr Protoc Microbiol. Nov 2009;Chapter 6:Unit 6C.1. [Medline].
Raoult D, Stein A. Q fever during pregnancy: a risk for the mother, for the fetus and for the obstetrician. N Engl J Med. 1994;330:371.
Ong C, Ahmad O, Senanayake S, Buirski G, Lueck C. Optic neuritis associated with Q fever: case report and literature review. Int J Infect Dis. Sep 2010;14 Suppl 3:e269-73. [Medline].
Carcopino X, Raoult D, Bretelle F, Boubli L, Stein A. Q Fever during pregnancy: a cause of poor fetal and maternal outcome. Ann N Y Acad Sci. May 2009;1166:79-89. [Medline].
Oyston PC, Davies C. Q fever: the neglected biothreat agent. J Med Microbiol. Jan 2011;60:9-21. [Medline].
Marrie TJ, Stein A, Janigan D, Raoult D. Route of infection determines the clinical manifestations of acute Q fever. J Infect Dis. Feb 1996;173(2):484-7. [Medline].
Marrie TJ. Q fever pneumonia. Infect Dis Clin North Am. Mar 2010;24(1):27-41. [Medline].
Waag DM. Coxiella burnetii: host and bacterial responses to infection. Vaccine. Oct 16 2007;25(42):7288-95. [Medline].
Cutler SJ, Bouzid M, Cutler RR. Q fever. J Infect. Apr 2007;54(4):313-8. [Medline].
Hartzell JD, Wood-Morris RN, Martinez LJ, Trotta RF. Q fever: epidemiology, diagnosis, and treatment. Mayo Clin Proc. May 2008;83(5):574-9. [Medline].
Raoult D, Tissot-Dupont H, Foucault C, et al. Q fever 1985-1998. Clinical and epidemiologic features of 1,383 infections. Medicine (Baltimore). Mar 2000;79(2):109-23. [Medline].
World Health Organization. Report of a WHO Group of Consultants. Health aspects of chemical and biological weapons. Geneva, Switzerland: WHO Press; 1970.
Karakousis PC, Trucksis M, Dumler JS. Chronic Q fever in the United States. J Clin Microbiol. Jun 2006;44(6):2283-7. [Medline]. [Full Text].
Centers for Disease Control and Prevention. Potential for Q fever infection among travelers returning from Iraq and the Netherlands. Available at http://emergency.cdc.gov/HAN/han00313.asp. Accessed May 12, 2010.
Schimmer B, Morroy G, Dijkstra F, et al. Large ongoing Q fever outbreak in the south of The Netherlands, 2008. Euro Surveill. Jul 31 2008;13(31):[Medline]. [Full Text].
Dupuis G, Petite J, Péter O, Vouilloz M. An important outbreak of human Q fever in a Swiss Alpine valley. Int J Epidemiol. Jun 1987;16(2):282-7. [Medline].
Terheggen U, Leggat PA. Clinical manifestations of Q fever in adults and children. Travel Med Infect Dis. May 2007;5(3):159-64. [Medline].
Scola BL. Current laboratory diagnosis of Q fever. Semin Pediatr Infect Dis. Oct 2002;13(4):257-62. [Medline].
Raoult D, Houpikian P, Tissot Dupont H, et al. Treatment of Q fever endocarditis: comparison of 2 regimens containing doxycycline and ofloxacin or hydroxychloroquine. Arch Intern Med. Jan 25 1999;159(2):167-73. [Medline].
Healy B, Llewelyn M, Westmoreland D, Lloyd G, Brown N. The value of follow-up after acute Q fever infection. J Infect. Apr 2006;52(4):e109-12. [Medline].
Fenollar F, Raoult D. Molecular diagnosis of bloodstream infections caused by non-cultivable bacteria. Int J Antimicrob Agents. Nov 2007;30 Suppl 1:S7-15. [Medline].
Healy B, van Woerden H, Raoult D, et al. Chronic Q fever: different serological results in three countries--results of a follow-up study 6 years after a point source outbreak. Clin Infect Dis. Apr 15 2011;52(8):1013-9. [Medline].
Brouillard JE, Terriff CM, Tofan A, Garrison MW. Antibiotic selection and resistance issues with fluoroquinolones and doxycycline against bioterrorism agents. Pharmacotherapy. Jan 2006;26(1):3-14. [Medline].
Moodie CE, Thompson HA, Meltzer MI, Swerdlow DL. Prophylaxis after exposure to Coxiella burnetii. Emerg Infect Dis. Oct 2008;14(10):1558-66. [Medline]. [Full Text].
Parker NR, Barralet JH, Bell AM. Q fever. Lancet. Feb 25 2006;367(9511):679-88. [Medline].
Raoult D, Fenollar F, Stein A. Q fever during pregnancy: diagnosis, treatment, and follow-up. Arch Intern Med. Mar 25 2002;162(6):701-4. [Medline].

